These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24191947)

  • 1. CRIMALDDI: a prioritized research agenda to expedite the discovery of new anti-malarial drugs.
    Ward SA; Boulton IC
    Malar J; 2013 Nov; 12():395. PubMed ID: 24191947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRIMALDDI: platform technologies and novel anti-malarial drug targets.
    Vial H; Taramelli D; Boulton IC; Ward SA; Doerig C; Chibale K
    Malar J; 2013 Nov; 12():396. PubMed ID: 24498961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives.
    Boulton IC; Nwaka S; Bathurst I; Lanzer M; Taramelli D; Vial H; Doerig C; Chibale K; Ward SA
    Malar J; 2010 Jul; 9():202. PubMed ID: 20626844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural products as starting points for future anti-malarial therapies: going back to our roots?
    Wells TN
    Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S3. PubMed ID: 21411014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efforts Aimed To Reduce Attrition in Antimalarial Drug Discovery: A Systematic Evaluation of the Current Antimalarial Targets Portfolio.
    Chaparro MJ; Calderón F; Castañeda P; Fernández-Alvaro E; Gabarró R; Gamo FJ; Gómez-Lorenzo MG; Martín J; Fernández E
    ACS Infect Dis; 2018 Apr; 4(4):568-576. PubMed ID: 29320160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges.
    Roy KK
    Int J Antimicrob Agents; 2017 Sep; 50(3):287-302. PubMed ID: 28668681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs.
    Tougan T; Toya Y; Uchihashi K; Horii T
    Malar J; 2019 Jan; 18(1):8. PubMed ID: 30642330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New targets, new hope: novel drug targets for curbing malaria.
    Arora N; Banerjee AK
    Mini Rev Med Chem; 2012 Mar; 12(3):210-26. PubMed ID: 22356192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in the development of anti-malarial quinolones.
    Beteck RM; Smit FJ; Haynes RK; N'Da DD
    Malar J; 2014 Aug; 13():339. PubMed ID: 25176157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents.
    Bahamontes-Rosa N; Gomez-Lorenzo MG; Lelièvre J; Rodriguez Alejandre A; Almela MJ; Lozano S; Herreros E; Gamo FJ
    Malar J; 2016 Jul; 15(1):385. PubMed ID: 27448565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent, novel, non-toxic anti-malarial compounds via quantum modelling, virtual screening and in vitro experimental validation.
    Sullivan DJ; Kaludov N; Martinov MN
    Malar J; 2011 Sep; 10():274. PubMed ID: 21933377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAPi: Computational Model for Apicoplast Inhibitors Prediction Against Plasmodium Parasite.
    Dixit S; Singla D
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):303-310. PubMed ID: 28260517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How can natural products serve as a viable source of lead compounds for the development of new/novel anti-malarials?
    Guantai E; Chibale K
    Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S2. PubMed ID: 21411013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in the identification and development of anti-malarial agents using virtual screening based approaches.
    Shah P; Tiwari S; Siddiqi MI
    Comb Chem High Throughput Screen; 2015; 18(3):257-68. PubMed ID: 25747437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches in antimalarial drug discovery.
    Held J; Kreidenweiss A; Mordmüller B
    Expert Opin Drug Discov; 2013 Nov; 8(11):1325-37. PubMed ID: 24090219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring anti-malarial potential of FDA approved drugs: an in silico approach.
    Ramakrishnan G; Chandra N; Srinivasan N
    Malar J; 2017 Jul; 16(1):290. PubMed ID: 28720135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive review on various strategies for antimalarial drug discovery.
    Mishra M; Mishra VK; Kashaw V; Iyer AK; Kashaw SK
    Eur J Med Chem; 2017 Jan; 125():1300-1320. PubMed ID: 27886547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial drug discovery - approaches and progress towards new medicines.
    Flannery EL; Chatterjee AK; Winzeler EA
    Nat Rev Microbiol; 2013 Dec; 11(12):849-62. PubMed ID: 24217412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The past, present and future of anti-malarial medicines.
    Tse EG; Korsik M; Todd MH
    Malar J; 2019 Mar; 18(1):93. PubMed ID: 30902052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.